Standard
Fictitious case narratives as a method in communication about cancer screening harms. / Gram, Emma Grundtvig; Brodersen, John Brandt; Hansen, Cæcilie; Jønsson, Alexandra Brandt Ryborg.
In:
BMJ Evidence-Based Medicine, Vol. 27, No. Supplement 1, 2022.
Research output: Contribution to journal › Conference abstract in journal
Harvard
Gram, EG, Brodersen, JB, Hansen, C & Jønsson, ABR 2022, '
Fictitious case narratives as a method in communication about cancer screening harms',
BMJ Evidence-Based Medicine, vol. 27, no. Supplement 1.
https://doi.org/10.1136/bmjebm-2022-podabstracts.47
APA
Gram, E. G., Brodersen, J. B., Hansen, C., & Jønsson, A. B. R. (2022).
Fictitious case narratives as a method in communication about cancer screening harms.
BMJ Evidence-Based Medicine,
27(Supplement 1).
https://doi.org/10.1136/bmjebm-2022-podabstracts.47
Vancouver
Author
Gram, Emma Grundtvig ; Brodersen, John Brandt ; Hansen, Cæcilie ; Jønsson, Alexandra Brandt Ryborg. / Fictitious case narratives as a method in communication about cancer screening harms. In: BMJ Evidence-Based Medicine. 2022 ; Vol. 27, No. Supplement 1.
Bibtex
@article{e4c33ae9e6154a9ca3ef7c35ce731795,
title = "Fictitious case narratives as a method in communication about cancer screening harms",
author = "Gram, {Emma Grundtvig} and Brodersen, {John Brandt} and C{\ae}cilie Hansen and J{\o}nsson, {Alexandra Brandt Ryborg}",
year = "2022",
doi = "10.1136/bmjebm-2022-podabstracts.47",
language = "Udefineret/Ukendt",
volume = "27",
journal = "BMJ Evidence-Based Medicine",
issn = "2515-446X",
publisher = "BMJ Publishing Group",
number = "Supplement 1",
}
RIS
TY - ABST
T1 - Fictitious case narratives as a method in communication about cancer screening harms
AU - Gram, Emma Grundtvig
AU - Brodersen, John Brandt
AU - Hansen, Cæcilie
AU - Jønsson, Alexandra Brandt Ryborg
PY - 2022
Y1 - 2022
U2 - 10.1136/bmjebm-2022-podabstracts.47
DO - 10.1136/bmjebm-2022-podabstracts.47
M3 - Konferenceabstrakt i tidsskrift
VL - 27
JO - BMJ Evidence-Based Medicine
JF - BMJ Evidence-Based Medicine
SN - 2515-446X
IS - Supplement 1
ER -
